We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current STOK market cap is 618.65M. The company's latest EPS is USD -1.9767 and P/E is -5.90.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | -2.48M | 3.31M | 2.8M | 4.22M | 4.83M |
| Operating Income | -33.26M | -27.23M | -29.59M | -28.37M | -29.34M |
| Net Income | -30.65M | -24.54M | -26.96M | -26.37M | -25.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 12.41M | 8.78M |
| Operating Income | -35.68M | -53.04M | -86.07M | -104.36M | -114.77M |
| Net Income | -32.33M | -52.24M | -85.81M | -101.07M | -104.7M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 256.92M | 239.89M | 228.34M | 205.18M | 307.76M |
| Total Liabilities | 66.72M | 66.89M | 68.78M | 64.84M | 65.05M |
| Total Equity | 190.2M | 173M | 159.57M | 140.34M | 242.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 228.75M | 297.93M | 238.87M | 256.07M | 228.34M |
| Total Liabilities | 4.32M | 11.85M | 21.09M | 71.22M | 68.78M |
| Total Equity | 224.43M | 286.08M | 217.78M | 184.85M | 159.57M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -43.16M | -60.42M | -81.07M | -24.57M | -42.04M |
| Investing | 76.56M | 91.18M | 105.95M | 9.99M | -78.29M |
| Financing | 45.1M | 45.66M | 53.01M | 1.72M | 122.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -31.06M | -42.22M | -66.91M | -31.87M | -81.07M |
| Investing | -1.63M | -1.05M | -76.43M | -45.88M | 105.95M |
| Financing | 149.76M | 108.11M | 1.28M | 46.41M | 53.01M |
| Market Cap | 618.65M |
| Price to Earnings Ratio | -5.90 |
| Price to Sales Ratio | 70.33 |
| Price to Cash Ratio | 3.23 |
| Price to Book Ratio | 3.87 |
| Dividend Yield | - |
| Shares Outstanding | 52.97M |
| Average Volume (1 week) | 544.1k |
| Average Volume (1 Month) | 630.39k |
| 52 Week Change | 124.62% |
| 52 Week High | 17.58 |
| 52 Week Low | 4.09 |
| Spread (Intraday) | 15.97 (69.59%) |
| Company Name | Stoke Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.stoketherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
